In my opinion Mark Zuckerberg should partnership with $WIX after $SHOP and Muse.
Using Wix's ecosystem of businesses and online stores might become much more capable shopping and commerce platform.
Base44 doing it's big job aswell could benefit him hard.
Teaming up with Shopify to make shopping and checkout easier in Muse. Shoppers find more. Shops sell more. More partnerships like this coming soon.
1
399
Bio / Pharma trial + FDA approval calendar.
November PDUFA calendar, updated 馃搮
Already read out:
$NRXP / ANDA approved early on Oct 30 (GDUFA date was Nov 10) / our Positive call hit / stock closed -14.7%
$AGIO / PDUFA pushed to Feb 1, 2027
Still ahead (13 FDA decisions):
Nov 14
$SMMT / Ivonescimab + chemo / EGFRm NSCLC
$CYTK / Aficamten / oHCM (label expansion)
solana:JJnFfDLQ5cSm5m36vBdTpS7zoPyoC4w7RAbkqj2pump / BXCL501 / Agitation in schizophrenia & bipolar
Nov 22
$CAPR / Deramiocel / DMD
$SVRA / Molgramostim / aPAP
Nov 27
$BBIO / BBP-418 / LGMD
$GSK / Neladalkib / ALK+ NSCLC
Nov 28
$PYPD / D-PLEX-100 / SSI
Nov 30
$COGT / Bezuclastinib + sunitinib / GIST
$RHHBY / Giredestrant / ER+/HER2- breast cancer
$VRTX / Povetacicept / IgAN
Date TBA
$REGN / Cemdisiran / Myasthenia gravis
$RHHBY / Gazyva / Primary membranous nephropathy
The image shows the first 6 decisions still ahead. $SMMT, $CAPR & $SVRA odds are unlocked.
$CYTK and solana:JJnFfDLQ5cSm5m36vBdTpS7zoPyoC4w7RAbkqj2pump odds are coming soon.
1
292
Seems like following Nancy Pelosi inside trading might make sense following democrats winning House and Senate midterms.
Remember that in Covid she was the voice of democrats leading House.
IMO results good for Biotech/Pharma, less for Data Centers (both need eachother anyway).
1
332
That's literally best analyse for anyone in doubt what time on the market we're in TECHNICALLY now.
As we know anything can happen in these unstable times but personally I'm bullish for Biotech heading towards 2027.
Would consider picking top quantum plays while still cheap.
Hedge funds just hit the panic button harder than at any time in the last ten years. Here is why that is good news for you.
Morgan Stanley tracks the total money its hedge fund clients have bet on stocks. When that total drops sharply, it means funds are being forced to cut positions, usually because their losses hit a limit. In the last 2 days, it fell 7.8%, a bigger unwind than the Covid crash, the GameStop squeeze, or the 2016 and 2018 selloffs.
Every time this number fell past 6% (2016, 2018 twice, 2020, 2021, 2025), the S&P 500 bottomed within a week or two and was higher one, three and six months later. Six out of six.
The reason is simple. Once the forced sellers have sold, there is nobody left to push prices down. Those same funds then have to buy back in, and that buying has powered every rebound in the table.
As for me, I am looking for great businesses that got dumped for no reason. That is where the bargains are.
2
314
One $PACB DNA read tell scientists what the DNA sequence is, how it is packaged inside the cell, which regions are accessible to proteins, and which parts are chemically methylated.
Multiple layers of DNA information from a single molecule, rather then separate experiments.
New on hg38: Fiber-seq, from the Stergachis and Vollger labs. One PacBio read reports sequence, chromatin accessibility and CpG methylation together, and is long enough to phase.
See our news for more: bit.ly/ucscGBfiberseq

ALT The imprinting control region of the KCNQ1OT1 long non-coding RNA on chromosome 11, in K562. Across the highlighted region the CpGs on one haplotype are nearly all methylated and those on the other are nearly all unmethylated, and it is the unmethylated haplotype that is open. The bottom track plots the difference between the two, red where it is most significant. Loss of methylation here has been associated with Beckwith-Wiedemann syndrome.
2
469
Imo $OCUL is worth adding to the list, if things go well as it seems like it should trade at least $20+, key approval confirmation pending.
4
566
$PACB has it's motion towards Earnings soon, wondering if it's gonna show similar scenario to last years tops/bottoms. Key thing is to break $4 otherwise we might still see pullbacks to the bottom areas.
So many partnerships came last months, question is if its priced in yet.
1
613













